1 - 25 of 62 results for author:"Fisher D.E." in Literature citations
Results Customize
› Repeat search in UniProtKB (13)
| An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Mitra D., Luo X., Morgan A., Wang J., Hoang M.P., Lo J., Guerrero C.R., Lennerz J.K., Mihm M.C., Wargo J.A. et al. Nature 491:449-453(2012) · Mapped (17) |
| Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF. Anghel S.I., Correa-Rocha R., Correa-Rochal R., Budinska E., Boligan K.F., Boliganl K.F., Abraham S., Colombetti S., Fontao L., Mariotti A. et al. Pigment Cell Melanoma Res 25:482-487(2012) · Mapped (12) |
| YY1 regulates melanocyte development and function by cooperating with MITF. Li J., Song J.S., Bell R.J., Tran T.N., Haq R., Liu H., Love K.T., Langer R., Anderson D.G., Larue L. et al. PLoS Genet. 8:e1002688-e1002688(2012) · Mapped (11) |
| Transcription factor E3, a major regulator of mast cell-mediated allergic response. Yagil Z., Hadad Erlich T., Ofir-Birin Y., Tshori S., Kay G., Yekhtin Z., Fisher D.E., Cheng C., Wong W.S., Hartmann K. et al. J. Allergy Clin. Immunol. 129:1357-1366.e5(2012) · Mapped (7) |
| A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Yokoyama S., Woods S.L., Boyle G.M., Aoude L.G., MacGregor S., Zismann V., Gartside M., Cust A.E., Haq R., Harland M. et al. |
| Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Feige E., Yokoyama S., Levy C., Khaled M., Igras V., Lin R.J., Lee S., Widlund H.R., Granter S.R., Kung A.L. et al. Proc. Natl. Acad. Sci. U.S.A. 108:E924-33(2011) · Mapped (7) |
| Regulation of MITF stability by the USP13 deubiquitinase. Zhao X., Fiske B., Kawakami A., Li J., Fisher D.E. |
| Dual roles of lineage restricted transcription factors: the case of MITF in melanocytes. Levy C., Fisher D.E. Transcription 2:19-22(2011) · Mapped (7) |
| Lighting a path to pigmentation: mechanisms of MITF induction by UV. Liu J.J., Fisher D.E. Pigment Cell Melanoma Res 23:741-745(2010) · Mapped (7) |
| Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Khaled M., Levy C., Fisher D.E. Genes Dev. 24:2276-2281(2010) · Mapped (11) |
| Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Levy C., Khaled M., Robinson K.C., Veguilla R.A., Chen P.H., Yokoyama S., Makino E., Lu J., Larue L., Beermann F. et al. Cell 141:994-1005(2010) · Mapped (30) |
| Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Stewart R.A., Sanda T., Widlund H.R., Zhu S., Swanson K.D., Hurley A.D., Bentires-Alj M., Fisher D.E., Kontaridis M.I., Look A.T. et al. Dev. Cell 18:750-762(2010) · Mapped (10) |
| Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line. Gordon P.M., Fisher D.E. J. Biol. Chem. 285:14109-14114(2010) · Mapped (3) |
| An oncogenic role for ETV1 in melanoma. Jane-Valbuena J., Widlund H.R., Perner S., Johnson L.A., Dibner A.C., Lin W.M., Baker A.C., Nazarian R.M., Vijayendran K.G., Sellers W.R. et al. Cancer Res. 70:2075-2084(2010) · Mapped (7) |
| Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Nishimura E.K., Suzuki M., Igras V., Du J., Lonning S., Miyachi Y., Roes J., Beermann F., Fisher D.E. Cell Stem Cell 6:130-140(2010) · Mapped (10) |
| GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Scott K.L., Kabbarah O., Liang M.C., Ivanova E., Anagnostou V., Wu J., Dhakal S., Wu M., Chen S., Feinberg T. et al. |
| Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. Zhao X., Graves C., Ames S.J., Fisher D.E., Spanjaard R.A. Cancer Res. 69:5218-5225(2009) · Mapped (2) |
| Transcriptional regulation in melanoma. Mitra D., Fisher D.E. Hematol. Oncol. Clin. North Am. 23:447-65, 2009:viii-viii(2009) · Mapped (7) |
| Imatinib targeting of KIT-mutant oncoprotein in melanoma. Jiang X., Zhou J., Yuen N.K., Corless C.L., Heinrich M.C., Fletcher J.A., Demetri G.D., Widlund H.R., Fisher D.E., Hodi F.S. Clin. Cancer Res. 14:7726-7732(2008) · Mapped (7) |
| Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage. Yokoyama S., Feige E., Poling L.L., Levy C., Widlund H.R., Khaled M., Kung A.L., Fisher D.E. Pigment Cell Melanoma Res 21:457-463(2008) · Mapped (8) |
| Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. Sato-Jin K., Nishimura E.K., Akasaka E., Huber W., Nakano H., Miller A., Du J., Wu M., Hanada K., Sawamura D. et al. FASEB J. 22:1155-1168(2008) · Mapped (7) |
| Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv. Kawakami A., Sakane F., Imai S., Yasuda S., Kai M., Kanoh H., Jin H.Y., Hirosaki K., Yamashita T., Fisher D.E. et al. J. Invest. Dermatol. 128:143-150(2008) · Mapped (5) |
| Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Lim S.D., Stallcup W., Lefkove B., Govindarajan B., Au K.S., Northrup H., Lang D., Fisher D.E., Patel A., Amin M.B. et al. Mol. Med. 13:160-165(2007) · Mapped (4) |
| Central role of p53 in the suntan response and pathologic hyperpigmentation. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., D'Orazio J., Fung C.Y., Schanbacher C.F., Granter S.R. et al. Cell 128:853-864(2007) · Mapped (50) |
| Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. D'Orazio J.A., Nobuhisa T., Cui R., Arya M., Spry M., Wakamatsu K., Igras V., Kunisada T., Granter S.R., Nishimura E.K. et al. Nature 443:340-344(2006) · Mapped (10) |